Episode Details
Back to EpisodesTryptyr Now Available in US
Published 10 months ago
Description
Alcon launches its recently approved dry eye drug Tryptyr; a potential $1 billion deal is made to advance extended-release therapies for eye diseases; and two companies with late-stage AMD drug candidates complete phase 3 enrollment.
Learn more about your ad choices. Visit megaphone.fm/adchoices